semaglutide fda US approves weight loss drug Wegovy to prevent cardiovascular events Ozempic picks up FDA indication

Retatrutide is an investigational once-weekly injectable triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and potentially increase energy expenditure

Glutathione Administration Glutathione, a powerful antioxidant naturally produced in the body, is administered to promote whole body skin whitening

Our weight management program is about more than just losing weight

Our peptides are carefully sourced to ensure quality and efficacy, offering a cutting-edge approach to wellness and rejuvenation

Appa, Y., Yohn, J., Stern, R., & Mehta, R